• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    2/14/24 6:21:28 AM ET
    $ALPA
    Medical/Dental Instruments
    Health Care
    Get the next $ALPA alert in real time by email
    SC 13G/A 1 d753057dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Carmell Corporation

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    142922103

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 142922103

     

     1   

     NAMES OF REPORTING PERSONS

     

     Balyasny Asset Management L.P.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     (a) ☐  (b) ☐

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0 (See Item 4)

       6   

     SHARED VOTING POWER

     

     None

       7   

     SOLE DISPOSITIVE POWER

     

     0 (See Item 4)

       8   

     SHARED DISPOSITIVE POWER

     

     None

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0 (See Item 4)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

     

     Not Applicable

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.0%

    12  

     TYPE OF REPORTING PERSON*

     

     IA, PN

    *SEE INSTRUCTIONS BEFORE FILLING OUT.


    CUSIP No. 142922103

     

     1   

     NAMES OF REPORTING PERSONS

     

     BAM GP LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     (a) ☐  (b) ☐

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0 (See Item 4)

       6   

     SHARED VOTING POWER

     

     None

       7   

     SOLE DISPOSITIVE POWER

     

     0 (See Item 4)

       8   

     SHARED DISPOSITIVE POWER

     

     None

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0 (See Item 4)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

     

     Not Applicable

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.0%

    12  

     TYPE OF REPORTING PERSON*

     

     HC, OO

    *SEE INSTRUCTIONS BEFORE FILLING OUT.


    CUSIP No. 142922103

     

     1   

     NAMES OF REPORTING PERSONS

     

     Balyasny Asset Management Holdings LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     (a) ☐  (b) ☐

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0 (See Item 4)

       6   

     SHARED VOTING POWER

     

     None

       7   

     SOLE DISPOSITIVE POWER

     

     0 (See Item 4)

       8   

     SHARED DISPOSITIVE POWER

     

     None

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0 (See Item 4)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

     

     Not Applicable

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.0%

    12  

     TYPE OF REPORTING PERSON*

     

     HC, PN

    *SEE INSTRUCTIONS BEFORE FILLING OUT.


    CUSIP No. 142922103

     

     1   

     NAMES OF REPORTING PERSONS

     

     Dames GP LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     (a) ☐  (b) ☐

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0 (See Item 4)

       6   

     SHARED VOTING POWER

     

     None

       7   

     SOLE DISPOSITIVE POWER

     

     0 (See Item 4)

       8   

     SHARED DISPOSITIVE POWER

     

     None

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0 (See Item 4)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

     

     Not Applicable

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.0%

    12  

     TYPE OF REPORTING PERSON*

     

     HC, OO

    *SEE INSTRUCTIONS BEFORE FILLING OUT.


    CUSIP No. 142922103

     

     1   

     NAMES OF REPORTING PERSONS

     

     Dmitry Balyasny

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     (a) ☐  (b) ☐

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0 (See Item 4)

       6   

     SHARED VOTING POWER

     

     None

       7   

     SOLE DISPOSITIVE POWER

     

     0 (See Item 4)

       8   

     SHARED DISPOSITIVE POWER

     

     None

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0 (See Item 4)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     ☐

     

     Not Applicable

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.0%

    12  

     TYPE OF REPORTING PERSON*

     

     HC, IN

    *SEE INSTRUCTIONS BEFORE FILLING OUT.


    Item 1    (a)    Name of Issuer:
          Carmell Corporation
       (b)    Address of Issuer’s Principal Executive Offices:
         

    2403 Sidney Street, Suite 300

    Pittsburgh, PA 15203

    United States

    Item 2    (a) – (c)    This statement is filed on behalf of the following:
         

    (1)   Balyasny Asset Management L.P. is a Delaware limited partnership (“BAM”), with its principal business office at 444 West Lake Street, 50th Floor, Chicago, IL 60606.

         

    (2)   BAM GP LLC is a Delaware limited liability company (“BAM GP”), with its principal business office at 444 West Lake Street, 50th Floor, Chicago, IL 60606. BAM GP is the General Partner of BAM.

         

    (3)   Balyasny Asset Management Holdings LP is a Delaware limited partnership (“BAM Holdings”), with its principal business office at 444 West Lake Street, 50th Floor, Chicago, IL 60606. BAM Holdings is the Sole Member of BAM GP.

         

    (4)   Dames GP LLC is a Delaware limited liability company (“Dames”), with its principal business office at 444 West Lake Street, 50th Floor, Chicago, IL 60606. Dames is the General Partner of BAM Holdings.

         

    (5)   Dmitry Balyasny, a United States citizen whose business address is 444 West Lake Street, 50th Floor, Chicago, IL 60606. Dmitry Balyasny is the Managing Member of Dames.

       (d)    Title of Class of Securities:
          Common Stock, par value $0.0001 per shares (“Shares”)
       (e)    CUSIP Number:
          142922103


    Item 3

    If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

      (a)    ☐    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
      (b)    ☐    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c)    ☐    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
         (d)    ☐    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e)    ☒    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f)    ☐    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
      (g)    ☒    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
      (h)    ☐    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
      (i)    ☐    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j)    ☐    A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k)    ☐    Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

    Item 4

    Ownership:

    BAM

     

      (a)

    Amount Beneficially Owned:

    By virtue of its position as the investment manager of Atlas Diversified Master Fund, Ltd. (“ADMF”), the direct holder of the 0 Shares reported herein, BAM may be deemed to exercise voting and investment power over such Shares held by ADMF and thus may be deemed to beneficially own such Shares.

     

      (b)

    Percent of Class:

    0.0%

     

      (c)

    Number of Shares as to which person has:

     

      (i)

    Sole power to vote or to direct vote:

    0


      (ii)

    Shared power to vote or to direct vote:

    None

     

      (iii)

    Sole power to dispose or direct disposition of:

    0

     

      (iv)

    Shared power to dispose or to direct disposition of:

    None

    BAM GP

     

      (b)

    Amount Beneficially Owned:

    By virtue of its position as the General Partner of BAM, BAM GP may be deemed to exercise voting and investment power over the Shares held directly by ADMF and thus may be deemed to beneficially own such Shares.

     

      (b)

    Percent of Class:

    0.0%

     

      (c)

    Number of Shares as to which person has:

     

      (i)

    Sole power to vote or to direct vote:

    0

     

      (ii)

    Shared power to vote or to direct vote:

    None

     

      (iii)

    Sole power to dispose or direct disposition of:

    0

     

      (iv)

    Shared power to dispose or to direct disposition of:

    None


    BAM Holdings

     

      (c)

    Amount Beneficially Owned:

    By virtue of its position as the Sole Member of BAM GP, BAM Holdings may be deemed to exercise voting and investment power over the Shares held directly by ADMF and thus may be deemed to beneficially own such Shares.

     

      (b)

    Percent of Class:

    0.0%

     

      (c)

    Number of Shares as to which person has:

     

      (i)

    Sole power to vote or to direct vote:

    0

     

      (ii)

    Shared power to vote or to direct vote:

    None

     

      (iii)

    Sole power to dispose or direct disposition of:

    0

     

      (iv)

    Shared power to dispose or to direct disposition of:

    None

    Dames

     

      (d)

    Amount Beneficially Owned:

    By virtue of its position as the General Partner of BAM Holdings, Dames may be deemed to exercise voting and investment power over the Shares held directly by ADMF and thus may be deemed to beneficially own such Shares.

     

      (b)

    Percent of Class:

    0.0%

     

      (c)

    Number of Shares as to which person has:

     

      (i)

    Sole power to vote or to direct vote:

    0


      (ii)

    Shared power to vote or to direct vote:

    None

     

      (iii)

    Sole power to dispose or direct disposition of:

    0

     

      (iv)

    Shared power to dispose or to direct disposition of:

    None

    Dmitry Balyasny

     

      (a)

    Amount Beneficially Owned:

    By virtue of his position as the Managing Member of Dames, Mr. Balyasny may be deemed to exercise voting and investment power over the Shares held directly by ADMF and thus may be deemed to beneficially own such Shares.

     

      (b)

    Percent of Class:

    0.0%

     

      (c)

    Number of Shares as to which person has:

     

      (i)

    Sole power to vote or to direct vote:

    0

     

      (ii)

    Shared power to vote or to direct vote:

    None

     

      (iii)

    Sole power to dispose or direct disposition of:

    0

     

      (iv)

    Shared power to dispose or to direct disposition of:

    None


    Item 5

    Ownership of Five Percent or Less of a Class:

    Not Applicable

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person:

    ADMF, a Cayman Islands exempted company that is an investment management client of BAM, has the right to receive dividends from, or the proceeds from the sale of, the reported securities.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

    Not Applicable

     

    Item 8

    Identification and Classification of Members of the Group:

    Not Applicable

     

    Item 9

    Notice of Dissolution of Group:

    Not Applicable

     

    Item 10

    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 12, 2024

     

    BALYASNY ASSET MANAGEMENT L.P.
    By:   /s/ Scott Schroeder
    Name:   Scott Schroeder
    Title:   Authorized Signatory
    BAM GP LLC
    By:   /s/ Scott Schroeder
    Name:   Scott Schroeder
    Title:   Authorized Signatory
    BALYASNY ASSET MANAGEMENT HOLDING LP
    By:   /s/ Scott Schroeder
    Name:   Scott Schroeder
    Title:   Authorized Signatory
    DAMES GP LLC
    By:   /s/ Scott Schroeder
    Name:   Scott Schroeder
    Title:   Authorized Signatory
    DMITRY BALYASNY
    By:   /s/ Dmitry Balyasny
    Get the next $ALPA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ALPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Shukla Rajiv was granted 14,347 shares and acquired 0 shares, increasing direct ownership by 42% to 48,526 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    1/4/24 9:17:09 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful completion of its business combination (the "Business Combination") with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). The resulting combined company, Carmell Therapeutics Corporation, is expected to commence trading of its shares of common stock and warrants on the Nasdaq Capital Market® under the ticker symbols "CTCX" and "CTCXW," respectively, on July 17, 2023.

    7/14/23 3:12:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding letter of intent (the "LOI") to acquire a commercial stage regenerative medicine company (the "Target") conditioned upon the closing of ALPA's initial business combination with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). ALPA has set a Stockholders Meeting (the "Meeting") to consider the previously announced business combination with Carmell for J

    6/27/23 7:00:00 AM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a definitive business combination agreement with Carmell Therapeutics Corporation ("Carmell™"), a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications. Upon closing of the transaction, ALPA will be renamed Carmell Therapeutics Corporation (the "Combined Company"). Mr. Shukla will serve as Chairman and Mr. Randy Hubbell will serve as Chief Executive Officer of the Combined Company. The Combined Company's common stock is expected to be listed on the Na

    1/4/23 10:11:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    SEC Filings

    View All

    $ALPA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:27:40 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:14:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:07:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Frisch Scott M. bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:12:55 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 4:13:13 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 3:42:33 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III

    SC 13G - Carmell Corp (0001842939) (Subject)

    2/14/24 12:54:27 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care